← Back to Search

Blood Flow Restriction Exercise for Spinal Cord Injury

N/A
Recruiting
Led By John McDaniel, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be between the ages of 18 and 75 years
All participants must be between the ages of 18 and 70 years and have a medically stable incomplete spinal cord injury (AIS C or D) at least 1-year post injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 1, 28 and 56 days
Awards & highlights

Study Summary

This trial will explore the benefits and risks of blood flow restriction exercise for people with incomplete spinal cord injuries.

Who is the study for?
This trial is for adults aged 18-70 with a stable incomplete spinal cord injury (AIS C or D), at least one year post-injury, and an injury level between C3-L1. It's not for pregnant women, those needing ventilators, with significant diseases like heart disease or uncontrolled diabetes, chronic inflammatory conditions, obesity (>30% body fat), recent or repeated DVTs history, on vasodilators, or with orthopedic issues preventing knee exercises.Check my eligibility
What is being tested?
The study tests the effectiveness of Blood Flow Restriction (BFR) exercise versus traditional resistance exercise in improving muscle and vascular function in individuals with spinal cord injuries. Participants will undergo two 8-week training periods focusing on knee extension/flexion exercises to compare changes in muscle strength and endurance as well as vascular health.See study design
What are the potential side effects?
Potential side effects may include increased risk of blood clots due to temporary blood stasis from BFR exercise. The safety aspect will be closely monitored by checking immune activation markers and thrombosis risk through regular blood tests.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 75 years old.
Select...
I am 18-70 years old with a stable spinal cord injury for over a year.
Select...
My spinal cord injury is between the C3 and L1 vertebrae.
Select...
My spinal cord injury is between C3 and L1.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 1, 28 and 56 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 1, 28 and 56 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in D-dimer
Change in muscle cross sectional area
Change in muscle fatigue resistance (percent decrease in maximal voluntary torque following fatigue protocol)
+5 more
Secondary outcome measures
Change in C-reactive protein (CRP)
Change in Hypoxia-inducible factor 1-alpha (HIF-1 )
Change in Interleukin 6
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: blood flow restriction exerciseExperimental Treatment1 Intervention
8 weeks (20 sessions) of blood flow restriction knee extension/flexion exercise
Group II: traditional resistance exerciseActive Control1 Intervention
8 weeks (20 sessions) of traditional knee extension/flexion resistance exercise

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,431 Total Patients Enrolled
John McDaniel, PhDPrincipal InvestigatorLouis Stokes VA Medical Center, Cleveland, OH

Media Library

Blood Flow Restriction exercise Clinical Trial Eligibility Overview. Trial Name: NCT04889092 — N/A
Spinal Cord Injury Research Study Groups: traditional resistance exercise, blood flow restriction exercise
Spinal Cord Injury Clinical Trial 2023: Blood Flow Restriction exercise Highlights & Side Effects. Trial Name: NCT04889092 — N/A
Blood Flow Restriction exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04889092 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are younger adults being considered as participants for this experiment?

"This medical trial requires all participants to be at least 18 years of age and not exceed the age of 70."

Answered by AI

Are there any available enrollments for this research endeavor?

"Clinicaltrials.gov indicates that this clinical trial continues to seek participants since its initial posting on July 1st 2021; the page was last updated on August 11th 2022."

Answered by AI

How many individuals have signed up to participate in this research?

"Affirmative. Clinicaltrials.gov hosts data which indicates that the recruitment process for this medical study, initially posted on July 1st 2021, is ongoing. 22 patients need to be found from a single research site."

Answered by AI

Am I eligible to be a contributing participant in this experiment?

"Individuals with spinal cord injury and aged between 18 to 70 are eligible for this trial. The total number of participants being accepted is 22 people."

Answered by AI

What are the major goals of this particular experiment?

"This trial will span 0 to 56 days with the primary purpose of examining changes in D-dimer levels. Secondary objectives include investigating modifications in interferon, NETosis, and reactive hyperemia via blood samples for analysis, NIRS (near infrared spectroscopy) imaging and Doppler/ultrasound scanning respectively."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
How old are they?
18 - 65
What site did they apply to?
Louis Stokes VA Medical Center, Cleveland, OH
What portion of applicants met pre-screening criteria?
Did not meet criteria
~2 spots leftby Aug 2024